Results 11 to 20 of about 6,804,228 (211)

Emerging concepts in HIV pre-exposure prophylaxis: focus on twice-yearly lenacapavir. [PDF]

Drugs Context
The persistent global burden of HIV and the need for more flexible, durable prevention strategies have accelerated the development of long-acting pre-exposure prophylaxis (PrEP) options.
Anderson SL.
europepmc   +2 more sources

Planning for pre-exposure prophylaxis to prevent HIV transmission: challenges and opportunities. [PDF]

, 2010
There are currently several ongoing or planned trials evaluating the efficacy of pre-exposure prophylaxis (PrEP) as a preventative approach to reducing the transmission of HIV.
Warren, M, Kim, SC, Dieffenbach, Carl, Blair S Hanewall, Becker, Stephen, Lo, Ying-Ru, Catherine Hankins, Paxton, L, Ying‐Ru Lo, Mellors, John W., Lo, YR, O'Reilly, K, John W Mellors, Dybul, MR, Mitchell Warren, Dybul, Mark R, Ying-Ru Lo, Susan C Kim, Hanewall, Blair S, Mellors, JW, Lynn Paxton, Roffenbender, JS, Paxton, Lynn, Kim, Susan C, Mellors, John W, Roffenbender, Jason S, Dieffenbach, C, Piot, P, Kevin O'Reilly, Peter Piot, Carl Dieffenbach, O'Reilly, Kevin, Stephen Becker, Hankins, Catherine, Piot, Peter, Warren, Mitchell, Hankins, C, Mark R Dybul, Becker, S, Hanewall, BS, Jason S Roffenbender   +40 more
core   +1 more source

Pre-Exposure prophylaxis studies (N = 19).

, 2022
Pre-Exposure prophylaxis studies (N = 19).
Mathias Lalika (12359774), Rena C. Patel (3387779), David M. Koelle (8138436), Aldina Mesic (12359768), Emahlea K. Jackson (12359771)   +4 more
core   +1 more source

Attitudes and acceptance of oral and parenteral HIV preexposure prophylaxis among potential user groups: a multinational study. [PDF]

, 2012
BACKGROUND: The use of antiviral medications by HIV negative people to prevent acquisition of HIV or pre-exposure prophylaxis (PrEP) has shown promising results in recent trials.
Garnett, Geoffrey P, Piot, PK, Ana Wheelock, Wheelock, A, Gomez Gabriela B., Wheelock, Ana, Gomez, Gabriela B, Geoffrey P Garnett, Eisingerich, Andreas B., Garnett Geoffrey P., Peter K Piot, Dybul Mark R., Mark R. Dybul, Dybul, MR, Gomez, Gabriela B., Dybul, Mark R., Dybul, Mark R, Peter K. Piot, Geoffrey P. Garnett, Gomez, GB, Piot, Peter K, Piot, Peter K., Gabriela B Gomez, Wheelock Ana, Andreas B Eisingerich, Garnett, Geoffrey P., Piot Peter K., Gabriela B. Gomez, Eisingerich, Andreas B, Eisingerich, AB, Garnett, GP, Mark R Dybul, Andreas B. Eisingerich, Eisingerich Andreas B.   +33 more
core   +2 more sources

Preexposure prophylaxis for HIV infection among African women. [PDF]

, 2012
BACKGROUND: Preexposure prophylaxis with antiretroviral drugs has been effective in the prevention of human immunodeficiency virus (HIV) infection in some trials but not in others.
FEM-PrEP Study Group, Mastro, Timothy D., Malahleha, M., Ahmed, K., Ahmed, Khatija, Fransen, K., Mastro, T. D., Makanda, M., Kiernan, H., Mastro, Timothy D, Reblin, I., Van Damme, Lut, Deese, j., Temu, Lucky, Agot, Kawango, Monedi, M. C., Mak'oketch, P., Deese, Jennifer, Owino, Fredrick, Nanda, Kavita, Kashuba, A., Mandala, Justin, Grant, R., Kapiga, S., Corneli, A., Makanda, Mankalimeng, Onyango, Jacob, Saylor, Lisa, Wong, Christina, Crucitti, Tania, Wong, C., Kirkendale, Stella, Kapiga, Saidi, Nanda, K., Taylor, Douglas, Makatu, S. E., Agot, K., Grant, Robert, Monedi, Modie Constance, Crucitti, T., Kiernan, Haddie, Kashuba, Angela, Makatu, Shumani Elsie, Mak'Oketch, Paul, Fransen, Katrien, Owino, F., Lombaard, Johan, Manongi, Rachel, Lombaard, J., Kirkendale, S., Reblin, Ilse, Onyango, J., Mandala, J., Saylor, L., Van Damme, L., Temu, L., Malahleha, Mookho, Taylor, D., Corneli, Amy, Manongi, R.   +59 more
core   +1 more source

Evaluation of cost-effective strategies for rabies post-exposure vaccination in low-income countries [PDF]

, 2011
<b>Background:</b> Prompt post-exposure prophylaxis (PEP) is essential in preventing the fatal onset of disease in persons exposed to rabies.
Hampson Katie, Katie Hampson, Briggs Deborah, Cleaveland, Sarah, Sarah Cleaveland, Briggs, Deborah, Deborah Briggs, Hampson, Katie, Cleaveland Sarah   +8 more
core   +1 more source

HIV pre-exposure prophylaxis : statewide plan and guidance

, 2022
The South Carolina Department of Health and Environmental Control (DHEC) HIV Pre-exposure Prophylaxis (PrEP) Statewide Plan and Guidance has been developed by DHEC as an element of the PrEPMeSC initiative.
Department of Health and Environmental Control. Division of STD/HIV and Viral Hepatitis
core  

Production, characterization, and antigen specificity of recombinant 62-71-3, a candidate monoclonal antibody for rabies prophylaxis in humans [PDF]

, 2013
Rabies kills many people throughout the developing world every year. The murine monoclonal antibody (mAb) 62-71-3 was recently identified for its potential application in rabies postexposure prophylaxis (PEP).
Both, L, Bulmer-Thomas, B., Banyard, AC, Selden, D., Altmann, F, Craig van Dolleweerd (406086), David Selden (4911475), Selden, D, Ashley C Banyard (16267520), Both, L., Banyard, A.C., Edward Wright (4468198), Bulmer-Thomas, B, Fooks, AR, Friedrich Altmann (33138), Wright, E, van Dolleweerd, C., Fooks, A.R., Ma, J.K.C., Julian K C Ma (16267529), Leonard Both (16267517), van Dolleweerd, C, Ma, JK, Wright, E., Altmann, F., Anthony R Fooks (16267526), Bianca Bulmer-Thomas (16267523)   +26 more
core   +1 more source

Pre-exposure prophylaxis (PrEP) uptake, by country and by reporting time period, with select COVID-19 mitigation strategies.

, 2022
Pre-exposure prophylaxis (PrEP) uptake, by country and by reporting time period, with select COVID-19 mitigation strategies.
Pragna Patel (240863), Sangeeta Rana (779840), Sara Klucking (12354820), Gaston Djomand (12354811), Sharon Stash (12354814), Anindya K. De (12354805), Ryan Keating (5343593), Michael Kerzner (12354802), Randy Yee (12354808), Robyn Eakle (4607374), Allison Kimmel (12354817)   +10 more
core   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman, Deborah Meyran, Vajiranee Malalasekera, Heather Weerdenburg, Janine Campbell, Rachel Conyers, Stacie Wang, Hannah Walker, Seong Lin Khaw, Diane Hanna   +9 more
wiley   +1 more source